Expertise in
6
conditions

Nicola Mordini

Cuneo, IT 
Expertise in
6
conditions
Cuneo, IT 

Overview

Nicola Mordini practices practicing medicine in Cuneo, Italy.

Ms. Mordini is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Graft.

She is actively involved in clinical research, co-authoring 41 peer reviewed articles and participating in 3 clinical trials.

Gender

Female

Locations

Cuneo, Italy
Other Locations
Alessandria, Italy
Avellino, Italy
Turin, Italy
Milan, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Prospective Observational Study for Evaluating Incidence, Severity and Outcomes of Chronic Graft-versus-Host Disease According to 2015 NIH Consensus Criteria
A Prospective Observational Study for Evaluating Incidence, Severity and Outcomes of Chronic Graft-versus-Host Disease According to 2015 NIH Consensus Criteria
Enrollment Status: Completed
Publish Date: November 25, 2022
TK008: Randomized Phase III Trial of Haploidentical HCT With or Without an Add Back Strategy of HSV-Tk Donor Lymphocytes in Patients With High Risk Acute Leukemia
TK008: Randomized Phase III Trial of Haploidentical HCT With or Without an Add Back Strategy of HSV-Tk Donor Lymphocytes in Patients With High Risk Acute Leukemia
Enrollment Status: Terminated
Publish Date: June 22, 2021
Intervention Type: Genetic, Other
Study Phase: Phase 3
Eltrombopag in Patients With Delayed Post Transplant Thrombocytopenia.
Eltrombopag in Patients With Delayed Post Transplant Thrombocytopenia.
Enrollment Status: Completed
Publish Date: June 11, 2021
Intervention Type: Drug
Study Drug: Eltrombopag
Study Phase: Phase 2
View 2 Less Clinical Trials

41 Total Publications

Early software-assisted response predicts survival in a prospective cohort of 258 newly diagnosed cGvHD patients.
Early software-assisted response predicts survival in a prospective cohort of 258 newly diagnosed cGvHD patients.
Journal: Bone marrow transplantation
Published: March 02, 2026

Frequently Asked Questions about Nicola Mordini

Is Nicola Mordini a top-rated expert for Bone Marrow Transplant?

MediFind is an objective health platform that identifies experts based on real-world data. Nicola Mordini is classified as an Distinguished expert for Bone Marrow Transplant, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Nicola Mordini participate in research or clinical trials?

Yes. Nicola Mordini has published 41 articles and abstracts on conditions like Bone Marrow Transplant. You can view a list of Nicola Mordini's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Mordini's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile